01. Doctor Overview
Dr. Lary Robinson is an expert in the evaluation and treatment of all stages of mesothelioma, currently practicing at the H. Lee Moffitt Cancer Center. He is board certified in Surgical Critical Care and is a Diplomat of the American Board of Surgery and the American Board of Thoracic Surgery. While serving on the Science Advisory Board of the Mesothelioma Applied Research Foundation, he also works on eight clinical cancer research programs. His research interests focus mainly on advanced lung cancer and aggressive surgical treatment of mesothelioma.
In addition to many awards and memberships, Dr. Robinson has published over 125 works including books, articles, studies and commentaries both as author and co-author, sharing his expertise with the cancer and mesothelioma community.
02. Fast Facts
Doctor Fast Facts
Main Specialty: Thoracic Surgery
Other Interests & Specialties: General cardiac/thoracic surgery, lung cancer, esophageal cancer and tumors of the chest, surgical critical care, heart disease, heart transplantation, bone cancer and aggressive surgical management of mesothelioma.
Certifications, Awards & Accolades: American Board of Surgery Certifications in Surgery and Critical Care, American Board of Thoracic Surgery Certification in Thoracic and Cardiac Surgery ACS Fellow, Physician of the Year Award, America’s Top Doctors Award, America’s Top Doctors for Cancer Award, Florida’s Top Doctors Award, Distinguished Service Award, FACCP Fellow
Education & Experience:
- Residency for General and Thoracic Surgery at Duke University Hospital
- Fellowships for Surgery and Cardiac Surgery at Duke University Hospital
- Fellowship for Cardiac Surgery at St. Thomas’ Hospital
- Medical Degree from Washington University School of Medicine in St. Louis
Did You Know?
Malignant pleural mesothelioma: A comprehensive review. Cancer Control. October 2006;13(4):255-63. doi: 10.1177/107327480601300402
Induction chemoradiotherapy versus chemotherapy alone for superior sulcus lung cancer. Lung Cancer. August 2018;122:206-213. doi: 10.1016/j.lungcan.2018.06.021
Localized mesothelioma: The clinical spectrum. Chest. November 1994;106(5):1611-5.